Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan, a generic and specialty pharmaceutical company, has announced the launch of Metoprolol Succinate Extended-release (ER) Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg, following FDA approval for its Abbreviated New Drug Application (ANDA).
Subscribe to our email newsletter
Metoprolol Succinate Extended-release (ER) Tablets are the generic version of AstraZeneca’s Toprol-XL Tablets, which are indicated for the treatment of hypertension.
The launch of the drug is believed to reflect Mylan’s continued commitment to bring difficult-to-formulate medicines to market.
According to IMS Health, Metoprolol Succinate ER Tablets generated sales of around $1.78bn for the 12 months ending 30 Sepember 2011, in the US.